François Raffi

2.5k total citations
26 papers, 1.7k citations indexed

About

François Raffi is a scholar working on Emergency Medicine, Infectious Diseases and Virology. According to data from OpenAlex, François Raffi has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Emergency Medicine, 16 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in François Raffi's work include HIV-related health complications and treatments (18 papers), HIV/AIDS drug development and treatment (12 papers) and HIV Research and Treatment (9 papers). François Raffi is often cited by papers focused on HIV-related health complications and treatments (18 papers), HIV/AIDS drug development and treatment (12 papers) and HIV Research and Treatment (9 papers). François Raffi collaborates with scholars based in France, Spain and United States. François Raffi's co-authors include Geneviève Chêne, Catherine Leport, Christine Katlama, M. Dupon, Philippe Morlat, P. Dellamonica, Virginie Gressin, D. Séréni, Olivier Sitbon and Gérald Simonneau and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

François Raffi

25 papers receiving 1.7k citations

Peers

Countries citing papers authored by François Raffi

Since Specialization

Citations

This map shows the geographic impact of François Raffi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Raffi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Raffi more than expected).

Fields of papers citing papers by François Raffi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Raffi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Raffi. The network helps show where François Raffi may publish in the future.

Co-authorship network of co-authors of François Raffi

This figure shows the co-authorship network connecting the top 25 collaborators of François Raffi. A scholar is included among the top collaborators of François Raffi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Raffi. François Raffi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 2022 ·Emerging infectious diseases ·(unknown), (unknown), (unknown), Romain Lemarié, (unknown), François Raffi, Stéphane Corvec, Morgane Le Bras, Charles Cazanave, Philippe Lehours, Thomas Guimard, Caroline Allix‐Béguec	10
2	Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1–positive individuals 2020 ·PLoS ONE ·(unknown), Javier Rodríguez-Centeno, Assia Samri, Julià Blanco, Natalia Stella-Ascariz, Cédrick Wallet, Hernando Knobel, David Zucman, (unknown), Brigitte Autran, Rodolphe Thiébaut, François Raffi, José Ramón Arribas, (unknown)	8
3	Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial 2019 ·The Lancet HIV ·(unknown), Giuliano Rizzardini, François Raffi, Federico Pulido, (unknown), Jean‐Michel Molina, Edmund Ong, (unknown), David Piontkowsky, Moupali Das, Ian R. McNicholl, Richard Haubrich	32
4	Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial 2019 ·PLoS ONE ·José Ignacio Bernardino, Amanda Mocroft, Cédrick Wallet, Christoph Stephan, Christine Katlama, Peter Reiss, Patrick Mallon, Laura Richert, Jean‐Michel Molina, Hernando Knobel, Philippe Morlat, Abdel Babiker, (unknown), François Raffi, José Ramón Arribas, (unknown)	14
5	Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study 2016 ·Medicine ·Paul de Boissieu, Moustapha Dramé, François Raffi, André Cabié, Isabelle Poizot‐Martin, Laurent Cotte, R. Garraffo, Pierre Delobel, Thomas Huleux, David Rey, Firouzé Bani‐Sadr	9
6	Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study 2016 ·PLoS ONE ·(unknown), Tristan Ferry, M. Dupon, Lise Cuzin, Renaud Verdon, Rodolphe Thiébaut, Camélia Protopopescu, Catherine Leport, François Raffi, Vincent Le Moing, (unknown)	46
7	Bone mineral density and inflammatory and bone biomarkers after darunavir–ritonavir combined with either raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial 2015 ·The Lancet HIV ·José Ignacio Bernardino, Amanda Mocroft, Patrick Mallon, Cédrick Wallet, Jan Gerstoft, Charlotte Russell, Peter Reiss, Christine Katlama, Christoph Stephan, Laura Richert, Abdel Babiker, Antonio Buño Soto, Antonella Castagna, Pierre-Marie Girard, Geneviève Chêne, François Raffi, José Ramón Arribas	58
8	Changes in Bone Mineral Density (BMD) over 96 Weeks on Darunavir/Ritonavir (DRV/r) + Raltegravir (RAL) or DRV/r + Tenofovir/Emtricitabine (TDF/FTC) 2014 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·José Ignacio Bernardino, Amanda Mocroft, Patrick Mallon, Cédrick Wallet, Peter Reiss, Christine Katlama, Christoph Stephan, Andrea Antinori, Jan Gerstoft, (unknown), Lucia Palmisano, (unknown), Juliette Saillard, François Raffi, José Ramón Arribas	0
9	Metabolic Syndrome in French HIV-Infected Patients: Prevalence and Predictive Factors After 3 Years of Antiretroviral Therapy 2012 ·AIDS Research and Human Retroviruses ·Antoine Biron, Christine Bobin‐Dubigeon, Christelle Volteau, Lionel Piroth, Philippe Van de Perre, Catherine Leport, Thiérry Prazuck, (unknown), Martine Billard, Véronique Sebille, Jean‐Marie Bard, François Raffi, Charlotte Biron	31
10	Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy 2012 ·BMJ Open ·Patrizia Carrieri, Camélia Protopopescu, Vincent Le Moing, (unknown), François Raffi, Sophie Mahy, Perrine Roux, Lise Cuzin, Bruno Spire, Catherine Leport, (unknown)	7
11	Peroxisome Proliferator Activating Receptor Alpha and Gamma Polymorphisms and Metabolic Abnormalities in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy: The ANRS CO8 APROCO-COPILOTE Study 2011 ·AIDS Research and Human Retroviruses ·Hassan Nazih, François Raffi, Audrey Taïeb, Jacques Reynes, P. Choutet, (unknown), Tristan Ferry, Geneviève Chêne, Catherine Leport, Jean‐Marie Bard	6
12	Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment 2011 ·AIDS ·J. Capeau, Vincent Bouteloup, Christine Katlama, Jean‐Philippe Bastard, Vincent Guiyedi, Dominique Salmon‐Céron, Camélia Protopopescu, (unknown), François Raffi, Geneviève Chêne	175
13	Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study 2009 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Tristan Ferry, François Raffi, (unknown), M. Dupon, P. Dellamonica, Anne Waldner, C. Strady, Geneviève Chêne, Catherine Leport, Vincent Le Moing	38
14	Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults 2009 ·AIDS ·(unknown), Xavier Duval, Vincent Le Moing, Lionel Piroth, (unknown), Patrice Massip, Virginie Villes, Geneviève Chêne, François Raffi	92
15	Prevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era 2007 ·American Journal of Respiratory and Critical Care Medicine ·Olivier Sitbon, Caroline Lascoux‐Combe, Jean‐François Delfraissy, Patrick Yéni, François Raffi, D. De Zuttère, Virginie Gressin, Pierre Clerson, D. Séréni, Gérald Simonneau	322
16	HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm3 on Long-Term Combination Antiretroviral Therapy Reach Same Mortality Rates as the General Population 2007 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Charlotte Lewden, Geneviève Chêne, Philippe Morlat, François Raffi, M. Dupon, P. Dellamonica, Jean‐Luc Pellegrin, Christine Katlama, François Dabis, Catherine Leport	305
17	Association of Apolipoproteins C3 and E with Metabolic Changes in HIV-Infected Adults Treated with a Protease-Inhibitor-Containing Antiretroviral Therapy 2006 ·Antiviral Therapy ·Jean‐Marie Bard, R. Lassalle, Jacqueline Capeau, Kalyane Bach‐Ngohou, (unknown), Gérard Rémy, Jacques Reynes, Jean-Luc Ecobichon, Marianne Savès, François Raffi	13
18	Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1 2004 ·PLoS Medicine ·Frank van Leth, (unknown), Erik S.G. Stroes, Brian Gazzard, Pedro Cahn, François Raffi, Robin Wood, Mark Bloch, Christine Katlama, John J.P. Kastelein, Mauro Schechter, Robert L. Murphy, Andrzej Horban, David B. Hall, Joep M. A. Lange, Peter Reiss	208
19	Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy 2002 ·Clinical Infectious Diseases ·Marianne Savès, François Raffi, Jacqueline Capeau, Willy Rozenbaum, Jean‐Marie Ragnaud, Christian Perronne, Arnaud Basdevant, Catherine Leport, Geneviève Chêne, (unknown)	202
20	A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients 1997 ·AIDS ·François Raffi, J Aboulker, C. Michelet, Véronique Reliquet, Hervé Pelloux, (unknown), Isabelle Poizot‐Martin, Philippe Morlat, B. Dupas, Jean‐Marie Mussini, Catherine Leport	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact